PA
ALT icon

Parallel Advisors’s Altimmune ALT Stock Holding History

Parallel Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123 Hold
40
– – ﹤0.01% 3780
2025
Q4 		$144 Hold
40
– – ﹤0.01% 3532
2025
Q3 		$151 Hold
40
– – ﹤0.01% 3458
2025
Q2 		$155 Hold
40
– – ﹤0.01% 3435
2025
Q1 		$200 Hold
40
– – ﹤0.01% 3378
2024
Q4 		$288 Hold
40
– – ﹤0.01% 3324
2024
Q3 		$246 Hold
40
– – ﹤0.01% 3274
2024
Q2 		$266 Hold
40
– – ﹤0.01% 3170
2024
Q1 		$407 Hold
40
– – ﹤0.01% 3087
2023
Q4 		$450 Hold
40
– – ﹤0.01% 3073
2023
Q3 		$104 Hold
40
– – ﹤0.01% 3277
2023
Q2 		$141 Hold
40
– – ﹤0.01% 3263
2023
Q1 		$169 Hold
40
– – ﹤0.01% 3296
2022
Q4 		$658 Hold
40
– – ﹤0.01% 2982
2022
Q3 		$1K Sell
40
-400
-91% -$5.91K ﹤0.01% 2835
2022
Q2 		$5K Buy
440
+386
+715% +$2.38K ﹤0.01% 2237
2022
Q1 		$0 Sell
54
-371
-87% -$2.73K ﹤0.01% 2940
2021
Q4 		$4K Sell
425
-309
-42% -$3.28K ﹤0.01% 2450
2021
Q3 		$8K Hold
734
– – ﹤0.01% 2155
2021
Q2 		$7K Hold
734
– – ﹤0.01% 2141
2021
Q1 		$10K Buy
+734
New +$11.9K ﹤0.01% 1907

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Parallel Advisors's ALT Position: Q1 2026 in Review

Parallel Advisors held its Altimmune (ALT) position steady in Q1 2026 at 40 shares worth $123. The position accounts for ﹤0.01% of the portfolio, ranked #3780.

Parallel Advisors first reported a position in ALT in Q1 2021 and has held it in 21 quarters since. The position peaked at $10K in Q1 2021. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Parallel Advisors held 40 shares of Altimmune worth $123 as of Q1 2026.
  • Parallel Advisors left its Altimmune share count unchanged in Q1 2026.
  • Altimmune made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3780 holding.
  • Parallel Advisors first reported a position in Altimmune in Q1 2021 and has held it in 21 quarters since.
  • Parallel Advisors's Altimmune position peaked at $10K in Q1 2021.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.